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an ExcellentOutpatientBridgato Tranaplantstion
andRecovery
J.J. OeRose, Jr., M. Argenziano, K.A. Cafanese, J.P. Umana,
M.T. Gardccki, M. Flannery, H.R. Levin, E.A. Rose, M.C. Oz.
Columbia-Presbyledan Medical Centec New York,NY USA
Seventy-six left ventricular assist devices (LVADS)(24 ventad electric (VE)
and 52 pneumatic) were implanted over a six year period at the Columbia-
Presbyterian Medical Center (CPMC) with an overall survival rate of 74%.
Sixly-one patienta (80%) were men and the age at the time of implant
was 50.8 * 12 yeara (mean + SD, range 13-65 years). Indications for
LVADimplantation included ischemic cardiomyopathy (42), idiopathic dilated
cardiomyopathy (29), myocarditis (3), hypertrophic cardiomyopathy (1) and
adriamycin-induced cardiomyopathy (l). Mean length of support was 106
+ 114 days (range 0-541 days). Forty-four patienta (56%) have undergone
successful cardiac transplantation, 3 were weaned off LVADsupport, and 9
are currently awaiting transplantation. Thromboembcdiccomplications were
rare, occurring in only 4 patients (0.015 per patient-month). Severe right
ventricular failure cccurrsd in 12% of patients and was managed with RVAD
placement (5), andlor inhaled nitric oxide (4). Five graft-related hemorrhages
have resulted in 2 deatha. Sixly-three patients (83%) were able to participate
in early, progressive rehabilitation. overall survival in the 24 VE patients was
83% with no deaths at transplant or explant. The mean length of support in
all VE patients was 123 + 154 days (range 3-541 days) with a total mean
hospital stay of 57 + 52 days. Seventeen VE patients (71%) left the hospital
while awaiting transplantation. Three patients had VE device malfunction
requiring replacement on days of suppoti 270, 365, and 296. Currently, 7
patients with VEa (2 in hospital, 5 at home) await transplant or explant. In
conclusion, the VE has allowed LVAD suppott in an outpatient setting. The
VE LVAD should be studied as a permanent treatment option for patients
who are not transplant candidates.
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n8042 AlteredMyocardialExpreaaionoflumor NacroaiaFactor-esAftarMechanicalSupportin PatientsWith
severeIdiopathicDilatadCardiomyopathy
R. Sangrigoli, S.E. Belland, M. Bernabei, J. Torres, B. Goldman,
V. Jeevanandam, H.J. Eisen. Temple University Phi/ada/phia, PA, USA
The cytokine Tumor Necrosis Factor-a (TNFw) is expressed by cardiac
myOO@s in the S0ttin9 of severe congestive heart failure (CHF) and likely
playa a major role in the pathogenesis of this disease. Left ventricular assist
devices, which are increasingly important in supporting patients with severe
CHF to cardiac transplantation, have recently been shown to reduce my-
ocyte size and atrial natriuretic peptide expression as a result of sustained
mechanical unloading of the failing myocardium. The effect of this unload-
ing on myocardial expression of TNF-a is unknown. We hypothesized that
myocardial expression of TNFw would be enhanced in patients with severe
CHF and that sustained unloading by LVADwould significantly reduce TNF-
a expression. We obtainad cardiac samples from six patients at the time of
LVAD placement and subsequently at the time of transplantation and these
were stained Immunohistochemically for TNF-a. Myocyte TNF-a expression
was scored in a qualitative and blinded fashion from O (no expression) to
3 (atrong, diffuse expression). Mean (+cSD) myocardial TNF-czexpression
was 2.5 + 0.8 prior to LVAD support vs. 0.8 + 1.1 after LVAD suppofl (p
< 0.05). Five patients had markedly reduced TNF-a expression after LVAD
support. One patient with the shortest period of LVADsuppoti had enhanced
myooyfeTNF-a expression. We conclude that LVADsupport and mechanical
unloading alter myocyte cytokine gene expression in patients with severe
CHF.
shown to improve cardiac output and diastolic coronay flow. It is also thought
to improve perfusion to vital organs. This study was done to evaluate the
effect of C on carotid artety blood flow (CABF) by measuring the flow velocity
integral (FVI) using carotid Duplex. We studied 14 patients who had an IABP
placed for clinical indications; 10 with hypotension after cardiac surgery or
myocardial infarction and 4 seconda~ to high riak coronary angioplasty. FVI
was measured in the common carotid artery (CCA) using a 5 MHz linear array
transducer (angle correction s 60Q),both with and without 1:1 augmentation.
Balloon inflation-deflation timing was thought to be optimal by the referring
physicians.
Resu/ta:There was no significant increase in net blood flow in the CCA
with C (total FVI with C = 19.3 + 1.55 cm vs 18.7 + 1.59 cm without C, p =
0.2). This was despite C augmenting diastolic CABF by 78% (diastolic FVI
with C = 13.9 + 1.2 cm vs 7.8 + 1.45 cm without’C, p < 0.001). There wea a
new early systolic reversal of CABF seen in every patient with C with a mean
FVI = –4.0 + 0.55 cm, which accounted for 21% of total CABF. There was
a small but significant decrease in the systolic FVI with C vs without (9.4 ~
0.85 cm vs 10.9 + 0.71 cm, p = 0.02). There was no change in the diameter
of the CCA with C.
Cone/usiona:Although there is significant diastolic augmentation, C from
the IABP does not increase total CABF. Early balloon deflation, prior to or
during isovolumetric contraction, occurs in the absence of left ventricular
ejection. Therefore, pressure in the aorta is lower than that in the csmtid
artery, resulting in a revereal of CABF and then a decrease in systolic flow.
This may result in no improvement in cerebral blood flow with C by IABP in
critically ill patients.
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NationalRagiatryfor EmergencyCardiopulmonary
BypaaaInvaatigatora
P.A.Overlie, F.A,Shawl, B.S. George, E.M. Ohman, M.R. Mooney,
R.J. Freedman, Jr., P.S.Teirstein, S.C. Smith, Jr., S. Stertzer, R.A. Vogel for
the National Registry of Emergency Cardiopulmonary Bypass Investigators.
MethodisVSt. Mary Hospitals Lubbock, Texas,USA
Weanalyzad pts receiving emergency cardiopulmonary bypass (ECPB) sup-
port for cardiogenic shock (CS) to evaluate outcomes and identify sutvivor-
ship characteristics. Literature suggests a grim sutvival rate in pts presenting
with CS, particularly those who are unresponsive to pressers. The registry
has a consecutive, prospective pt enrollment from multiple centers reflect-
ing a total of 109/375 (29%) CS pts. The remainder, 26W375 (71%) were
cardiac arrest (CA) pts. 47/109 (43%) CS pts undergoing ECPB suwivad in
follow-up to one year. 82Y0(51/62) survived until after surgery. 41/62 (66%)
of non-survivom had concomitant IABP which did not appear to statistically
improve the long-term survival.
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Survivors demonstrated no statistical difference in median EF to non-
survivora (36Y0 vs 32%). Pts undergoing surgery (52/109 or 46Yo) had a
survival rate of 50% (26/52) at one year. The remaining 57/109 were treated
medically and 21/57 (37%) survived to follow-up.
Cone/usiona:The use of ECPB in CS ptsas a bridge to surgical correction
isa lifesavingapplication of this support system. Survival rate appears related
to candidacy for and subsequent use of revascularization surgery.
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n8043 Intra-aorticBalloonPumpingDoaaNotImproveCarotidArtaryBloodFlow
R.M. Applebsum, H.H. Wun, E.S. Katz, P.A.Tunick, 1.Kronzon. NYU
Medical Centec NYC, NX USA
Counterpulaation (C) with the intraaortic balloon pump (IABP) has been
